Marshall Wace’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-700
Closed -$89.8K – 3324
2025
Q3
$89.8K Buy
+700
New +$85.4K ﹤0.01% 2670

Other funds holding NVS

Marshall Wace's NVS Position: Q3 2026 in Review

Marshall Wace sold out of Novartis (NVS) in Q3 2026, closing a stake of 330,061 shares — an estimated $51.7M sold.

Marshall Wace first reported a position in NVS in Q4 2014 and held it in 25 quarters. The position peaked at $173M in Q2 2025. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Marshall Wace reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
  • Marshall Wace sold 330,061 Novartis shares in Q3 2026, an estimated $51.7M.
  • Marshall Wace first reported a position in Novartis in Q4 2014 and held it in 25 quarters.
  • Marshall Wace's Novartis position peaked at $173M in Q2 2025.
  • 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.